Baylin, S.B. (2003). GATA-4 and GATA-5 transcription factor genes
and potential downstream antitumor target genes are epigenetically
silenced in colorectal and gastric cancer. Mol. Cell. Biol. 23, 84298439.

Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J.,, and
Clarke, M.F. (2003). Prospective identification of tumorigenic breast
cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988.

Bakker, J,Lin, X:., and Nelson,W.G. (2002).Methyl-CpG binding
domain protein 2 represses transcription from hypermethylated piclass glutathione S-transferase gene promoters in hepatocellular
carcinoma cells. J Biol. Chem. 27Z7, 22573-~-22580.

Baylin,S.B.,and Ohm, J.E.(2006).¡¢Epigenetic gene silencing in
cancer - a mechanism for early oncogenic pathway addiction? Nat.
Rev. Cancer 6, 107-~116.

Belinsky,S.A.,Nikula,K.JJ.,Palmisano,W.A.,Michels,R.,SacComanno,G.,Gabrielson,E:.,Baylin,S.B.,and Herman,J.G. (1998),
Aberrant methylation of p16(INK4a) is an early event in lung cancer
and a potential biomarker for early diagnosis. Proc. Natl. Acad. Sci.
USA 95, 11891-11896.

Bernstein, B.E., Mikkelsen, T.S.,Xie,X.,, Kamal, M.,Huebert,D.J.,,Cuff,
J, Fry, B., Meissner, A., Wernig, M., Plath, kK., et al. (2006a). A bivalent
chromatin structure marks key developmental genes in embryonic
stem cells. Cel| 125, 315-~326.

Bernstein,E., Duncan, E.M., Masui,O.,Gil, J.,Heard,E.,and Allis, C.D.
(2006b). Mouse polycomb proteins bind differentially to methylated
histone H3 and RNA and are enriched in facultative heterochromatin.
Mol. Cell. Biol. 26, 2560-~2569.

Bjerkvig, R., Tysnes, B.B.,, Aboody, K.S.,, Najbauer, J.,and Terzis, AJ,
(2005). Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat. Rev. Cancer 5, 899-904.

Bolden,J.E:,Peart,M.J:, and Johnstone,R.W. (2006). Anticancer
activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 5,
769-~784.

Boyer, L.A.,Plath, kK., Zeltlinger,J.,Brambrink, 1., Medeiros, L.A., Lee,
T Levine, S.S., Wernig, M.,, Tajonar, A., Ray, M.K., etal. (2006). Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349-353.

Bracken, A.P.,Dietrich, N.,Pasini, D.,Hansen,K.H., and Helin,kKk.
(2006). Genome-wide mapping of Polycomb target genes unravels
their roles in cell fate transitions. Genes Dev. 20, 1123-~1136.

Bracken,A.P., Pasini, D., Capra, M., Prosperinij, E.,, Colli E.,, and Helin,
K. (2003). EZH2 is downstream of the pRB-E2F pathway, essential for
proliferation and amplified in cancer. EMBO J 22, 5323-~5335.

Brueckner, B., Boy, R.G., Siedlecki,P.,, Musch, T., Kliem, H.C., Zielenkiewicz, P., Suhai, S., Wiessler, M., and LykKko, F. (2005). Epigenetic
reactivation of tumor suppressor genes by a novel small-molecule inhibitorofhuman DNAmethyltransferases. Cancer Res. 65, 6305-~6311.

Cadieux, B.,, Ching, T.T., Vandenberg, S.R., and Costello, J.F. (2006).
Genome-wide hypomethylation in human glioblastomas associated
with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.Cancer Res. 66,
8469-~8476.

Cameron,E.E., Bachman,kK.E., Myohanen,S., Herman,J.G.,and Baylin,S.B. (1999). Synergy of demethylation and histone deacetylase
inhibition in the re-expression of genes silenced in cancer. Nat. Genet.
21 , 103-~107.

Chal, J, Charboneau, A.L., Betz, B.L., and Weissman, B.E. (2005).
Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1
and p16INK4a activity associated with replicative senescence in
A204 rhabdoid tumor cells. Cancer Res. 65, 10192-~10198.

Chen, W.Y.,, Wang, D.H., Yen, R.C., Luo, J., Gu, W., and Baylin, S.B.
(2005). Tumor suppressor HIC1 directly regulates SIRT1 to modulate
p53-dependent DNA-damage responses. Cell 123, 437-448.

690 ¡°Cell 128, 683-~-692, February 23, 2007 @2007 EIlsevier InC.

Cheng, J.C., Yoo, C.B., Weisenberger, DJJ., Chuang, J., Wozniak, C.,
Liang, G., Marqguez,V.E., Greer, S., Orntoft, T.F., Thykjaer, T,and
Jones, P.A. (2004). Preferential response of cancer cells to zebularine.
Cancer Cell 6, 151-158.

Chuang, J.C., Yoo, C.B.,, Kwan, J.M., Lb, T.W., Liang, G., Yang, A.S.,
and Jones, P.A. (2005). Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2¡¸-deoxycytidine. Mol.
Cancer Ther. 4, 1515-~1520.

Constantinides, P.G., Jones, P.A., and Gevers, W. (1977). Functional
striated muscle cellsfrom non-myoblast precursors following 5-azacytidine treatment. Nature 267, 364-~366.

Cornacchia, E.,, Golbus,J.,, Maybaum, J., Strahler, J.,, Hanash, S., and
Richardson, B. (1988). Hydralazine and procainamide inhibit T cel|
DNA methylatilon and induce autoreactivity. J Immunol. 140, 2197 Ò»
2200.

Coussens, L.M.,and Werb, Z. (2002).Inflammation and cancer. Nature
420, 860-867.

Eckhardt, F., Lewin, J., Cortese, R., Rakyan, V.K., Attwood,J., Burger,
M., Burton, J, Cox, T.V.,Davies, R., Down, T.A., et al. (2006). DNA
methylation profiling ofhuman chromosomes 6, 20 and 22. Nat. Genet.
38, 1378-1385.

Esteller, M., Sparks, A.,Toyota, M., Sanchez-Cespedes, M., Capella,
G., Peinado,M.A., Gonzalez, S., Tarafa, G., Sidransky, D.,Meltzer,
S Ð¡ , et al. (2000). Analysis of adenomatous polyposis coli promoter
hypermethylation in human cancer. Cancer Res. 60, 4366-4371.

Esteller, M., Fraga, M.F., Guo, M., Garcia-Foncillas, J,, Hedenfalk, |.,
Godwin, A.K., Trojan, J,, Vaurs-Barriere, C., Bignon, Y.J.,, Ramus, S.,
et al. (2001). DNA methylation patterns in hereditary human cancers
mimic sporadic tumorigenesis. Hum. Mol. Genet. 10, 3001-3007.

Fang, M.Z., Wang, Y.,, Alj,N.,, Hou,Z., Sun, Y., Lu, H., Welsh, W., and
Yang,C.S. (2003). Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced
genes in cancer cell lines. Cancer Res. 63, 7563-7570.

Feinberg,A.P.,and Tycko,B. (2004).The history of cancer epigenetics.
Nat. Rev. Cancer 4 , 143-~153.

Feinberg, A.P., Ohlsson, R., and Henikoff, S. (2006). The epigenetic
progenitor origin of human cancer. Nat. Rev. Genet. 7, 21-33.

Foster, S.A., Wong, D.J, Barrett, M.T.,, and Galloway, D.A. (1998). Inactivation of p16 in human mammary epithelial cells by CpG island
methylation. Mol. Cell. Biol. 18, 1793-~-1801.

Fraga, M.F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada,
J Schotta, G., Bonaldi, T,, Haydon, C., Ropero, S., Petrie,K., et a
(2005). Loss of acetylation at Lys16 and trimethylation at Lys20 of
histone H4 is a common hallmark of human cancer. Nat. Genet. 37,
391-400.

Frigola,J.,, Song, J Stirzaker, C., Hinshelwood, R.A., Peinado, M.A.,
and Clark, SJ. (2006). Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome
band. Nat. Genet. 38, 540-~549.

Futscher,B.W.,Oshiro,M.M., Wozniak,R.J.,,Holtan,N., Hanigan, C.L.,
Duan, H., and Domann, F.E. (2002). Role for DNA methylation in the
control of cell type specific maspin expression. Nat. Genet. 31, 175179.

Gao, X.,, Sedgwick, T., Shi,Y.B.,, and Evans, T. (1998). Distinct functions are implicated for the GATA-4, -5, and -6 transcription factors
in the regulation of intestine epithelial cell differentiation. Mol. Cell
Biol. 18, 2901-2911.

Graff, J.R., Herman, J.G., Lapidus, R.G., Chopra, H., Xu, R., Jarrard,
D.F., Ilsaacs,W.B.,Pitha,P.M.,Davidson,N.E:,and Baylin,S.B.
(1995). E-cadherin expression is silenced by DNA hypermethylation
in human breast and prostate carcinomas. Cancer Res. 55,51955199.
